Fresenius Kabi And Formycon Ally On Stelara Rival

German Firms Strike Global Licensing Agreement For FYB202 Ustekinumab Biosimilar

 
• By David Wallace
  
Deal handshake global
Formycon and Fresenius have struck a deal on FYB202 • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business